ArticleNutrition journal2025
Daily eating frequency, nighttime fasting duration, and the risk of non-alcoholic fatty liver disease: a cross-sectional study.
Article in Nutrition journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe understanding of daily eating frequency (DEF) and nighttime fasting duration (NFD) is limited. The aim of this research is to investigate the links between DEF, NFD, and non-alcoholic fatty liver disease (NAFLD).
methodsThe research involved 11,153 participants from the National Health and Nutrition Examination Survey (NHANES) conducted between 2005 and 2018. The evaluation of DEF and NFD was conducted through interviews focusing on dietary recalls spanning 24 h. DEF refers to the overall number of times individuals eat throughout the day, whereas NFD indicates the duration between the last and first meal of the day. The diagnosis of NAFLD was established through the application of the US fatty liver index (USFLI). A weighted logistic regression model investigated the connection between DEF, NFD, and NAFLD.
resultsAfter full adjustment, participants with DEF ≤ 3 times exhibited a 21% higher risk of NAFLD than those with DEF > 4.5 times (OR = 1.21, 95% CI: 1.01-1.45). Similarly, individuals with NFD ≥ 14 h were 26% more likely to develop NAFLD than those with NFD ≤ 10 h (OR = 1.26, 95% CI: 1.04-1.53). The effect of DEF on NAFLD risk was more evident in participants without T2D and with low fibrosis risk, whereas the adverse impact of NFD was particularly pronounced among those younger than 60 years.
conclusionDEF below 3 times and NFD exceeding 14 h were significantly linked to a heightened risk of developing NAFLD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.